mRNA-1195

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for mRNA-1195, covering 2025-09-30 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years [Phase 2]

See pricing